Group II and III metabotropic glutamate receptor agonists: new therapeutic agents for the combined symptomatic and neuroprotective treatment of Parkinson's disease?

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/2001 → 31/05/2002

Funding

  • Wellcome Trust: £69,904.00